Dr. Richard “Rick” Winneker mentioned recommendation that he would offer to sufferers confronted with a myeloproliferative neoplasm (MPN) analysis, placing an emphasis in customized care and lively participation within the broader MPN neighborhood. He additionally goes on to emphasise the significance of consulting an MPN specialist to make sure optimum care.
Winneker, who presently works with the MPN Analysis Basis, creating and managing applications, was acknowledged on the CURE® MPN Heroes occasion for his dedication in uniting the affected person, doctor and pharmaceutical communities collectively in creating consciousness for MPN analysis.
In an interview, Winneker sat down with CURE and shared his professional insights on affected person care, in addition to expanded on the significance of participation in teams just like the MPN Analysis Basis to make sure a excessive prioritization of analysis and collaboration throughout the sector. Learn extra from the interview under.
Transcript:
The very first thing I do once I meet a affected person, moderately than giving them recommendation immediately, is ask them how they’re doing. I need to perceive what they’re experiencing as a result of I do know it may be so completely different from one affected person to the subsequent. [However], my recommendation often is: if doable, attempt to see an MPN specialist, if indirectly, however maybe a second opinion or a session of some form. They’re those which are actually carefully following this quickly rising discipline, [therefore] you need to just be sure you’re experiencing the very best outcomes that you would be able to.
Secondly, I’d say be your individual greatest advocate. Not solely that, [but] be a part of the MPN Analysis Basis. Work with us and be a part of that answer that we’re making an attempt to deliver ahead. We need to hear from sufferers about what they care about most, by way of what we must be doing subsequent. See the precise folks and be a part of us. I believe that will be my message.
Transcript was edited for readability and conciseness.
For extra information on most cancers updates, analysis and training, don’t neglect to subscribe to CURE®’s newsletters right here.
